应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALT Altimmune, Inc.
休市中 03-13 16:00:00 EDT
3.50
-0.10
-2.78%
盘后
3.50
+0.00
+0.07%
19:59 EDT
最高
3.68
最低
3.47
成交量
311.91万
今开
3.62
昨收
3.60
日振幅
5.83%
总市值
4.55亿
流通市值
4.34亿
总股本
1.30亿
成交额
1,099万
换手率
2.52%
流通股本
1.24亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
RootData:ALT 将于一周后解锁价值约 201 万美元的代币
链捕手 · 02-19
RootData:ALT 将于一周后解锁价值约 201 万美元的代币
Altimmune, Inc.盘中异动 早盘股价大涨5.12%报5.95美元
市场透视 · 01-27
Altimmune, Inc.盘中异动 早盘股价大涨5.12%报5.95美元
RootData:ALT 将于一周后解锁价值约 290 万美元的代币
链捕手 · 01-19
RootData:ALT 将于一周后解锁价值约 290 万美元的代币
Altimmune, Inc.盘中异动 股价大涨5.02%报4.39美元
市场透视 · 01-16
Altimmune, Inc.盘中异动 股价大涨5.02%报4.39美元
Altimmune, Inc.股价重挫14.34% 市值跌6472.42万美元
市场透视 · 2025-12-19
Altimmune, Inc.股价重挫14.34% 市值跌6472.42万美元
Altimmune宣布Pemvidutide在Impact 2B Mash试验中48周内实现主要成功指标
美股速递 · 2025-12-19
Altimmune宣布Pemvidutide在Impact 2B Mash试验中48周内实现主要成功指标
RootData:ALT 将于一周后解锁价值约 269 万美元的代币
链捕手 · 2025-12-19
RootData:ALT 将于一周后解锁价值约 269 万美元的代币
Altimmune, Inc.申请最高达4亿美元的混合货架证券 - SEC申请
投资观察 · 2025-11-20
Altimmune, Inc.申请最高达4亿美元的混合货架证券 - SEC申请
Altimmune修订与海格投资的贷款及担保协议 - SEC备案
投资观察 · 2025-11-20
Altimmune修订与海格投资的贷款及担保协议 - SEC备案
RootData:ALT 将于一周后解锁价值约 358 万美元的代币
链捕手 · 2025-11-19
RootData:ALT 将于一周后解锁价值约 358 万美元的代币
Altimmune公布IMPACT 2B期临床试验数据在《柳叶刀》上发表,并且于2025年AASLD肝脏会议上进行最新口头报告
美股速递 · 2025-11-11
Altimmune公布IMPACT 2B期临床试验数据在《柳叶刀》上发表,并且于2025年AASLD肝脏会议上进行最新口头报告
Altimmune宣布完成Reclaim II期试验的早期招募,评估Pemvidutide在酒精使用障碍中的应用
美股速递 · 2025-11-03
Altimmune宣布完成Reclaim II期试验的早期招募,评估Pemvidutide在酒精使用障碍中的应用
Altimmune 将于2025年11月6日公布2025年第三季度财务业绩并提供业务更新
美股速递 · 2025-10-30
Altimmune 将于2025年11月6日公布2025年第三季度财务业绩并提供业务更新
RootData:ALT 将于一周后解锁价值约 473 万美元的代币
链捕手 · 2025-10-19
RootData:ALT 将于一周后解锁价值约 473 万美元的代币
Altimmune, Inc.盘中异动 下午盘股价大涨5.10%报4.12美元
市场透视 · 2025-09-26
Altimmune, Inc.盘中异动 下午盘股价大涨5.10%报4.12美元
RootData:ALT 将于一周后解锁价值约 880 万美元的代币
链捕手 · 2025-09-19
RootData:ALT 将于一周后解锁价值约 880 万美元的代币
Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元
市场透视 · 2025-03-11
Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元
Altimmune, Inc.2024财年实现净利润-95.06百万美元,同比减少7.47%
市场透视 · 2025-03-08
Altimmune, Inc.2024财年实现净利润-95.06百万美元,同比减少7.47%
Altimmune, Inc.盘中异动 股价大跌5.07%
市场透视 · 2025-03-07
Altimmune, Inc.盘中异动 股价大跌5.07%
HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
金融界 · 2025-03-04
HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
加载更多
公司概况
公司名称:
Altimmune, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide(原名ALT-801)是一种GLP-1/胰高血糖素双受体激动剂,正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎(“MASH”),以前称为非酒精性脂肪性肝炎(“NASH”)。
发行价格:
--
{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":3.5,"timestamp":1773432000000,"preClose":3.6,"halted":0,"volume":3119120,"hourTrading":{"tag":"盘后","latestPrice":3.5026,"preClose":3.5,"latestTime":"19:59 EDT","volume":55645,"amount":194771.1043,"timestamp":1773446392906,"change":0.0026,"changeRate":0.000743,"amplitude":0.008314},"delay":0,"changeRate":-0.0277777777777778,"floatShares":124000000,"shares":130070000,"eps":-0.999873,"marketStatus":"休市中","change":-0.1,"latestTime":"03-13 16:00:00 EDT","open":3.62,"high":3.68,"low":3.47,"amount":10990667.537544,"amplitude":0.058333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.999873,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.6,"preHourTrading":{"tag":"盘前","latestPrice":3.61,"preClose":3.6,"latestTime":"09:29 EDT","volume":5897,"amount":21335.5724448,"timestamp":1773408541086,"change":0.01,"changeRate":0.002778,"amplitude":0.041667},"postHourTrading":{"tag":"盘后","latestPrice":3.5026,"preClose":3.5,"latestTime":"19:59 EDT","volume":55645,"amount":194771.1043,"timestamp":1773446392906,"change":0.0026,"changeRate":0.000743,"amplitude":0.008314},"volumeRatio":0.7744494164933123,"impliedVol":0.3237,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2612271476","title":"RootData:ALT 将于一周后解锁价值约 201 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2612271476","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612271476?lang=zh_cn&edition=full","pubTime":"2026-02-19 11:00","pubTimestamp":1771470005,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据Web3资产数据平台 RootData 代币解锁数据,AltLayer(ALT)将于北京时间 02 月 26 日 8 时解锁约 24659 万枚代币,价值约 201 万美元。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2246679","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2606793152","title":"Altimmune, Inc.盘中异动 早盘股价大涨5.12%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606793152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606793152?lang=zh_cn&edition=full","pubTime":"2026-01-27 23:57","pubTimestamp":1769529467,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日23时57分,Altimmune, Inc.股票出现波动,股价大幅拉升5.12%。截至发稿,该股报5.95美元/股,成交量148.165万股,换手率1.42%,振幅5.81%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为1.64%。Altimmune, Inc.公司简介:Altimmune Inc 是一家处于临床阶段的生物制药公司,专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127235747953e9968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127235747953e9968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2604904833","title":"RootData:ALT 将于一周后解锁价值约 290 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2604904833","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604904833?lang=zh_cn&edition=full","pubTime":"2026-01-19 11:00","pubTimestamp":1768791609,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据Web3资产数据平台 RootData 代币解锁数据,AltLayer(ALT)将于北京时间 01 月 26 日 8 时解锁约 24659 万枚代币,价值约 290 万美元。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2238485","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"gpt_icon":0},{"id":"2603938741","title":"Altimmune, Inc.盘中异动 股价大涨5.02%报4.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603938741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603938741?lang=zh_cn&edition=full","pubTime":"2026-01-16 02:02","pubTimestamp":1768500148,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日02时02分,Altimmune, Inc.股票出现异动,股价急速拉升5.02%。截至发稿,该股报4.39美元/股,成交量270.962万股,换手率2.60%,振幅8.02%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.72%。Altimmune, Inc.公司简介:Altimmune Inc 是一家处于临床阶段的生物制药公司,专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116020228a4c8952d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116020228a4c8952d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","LU1878469433.USD","BK4139"],"gpt_icon":0},{"id":"2592145299","title":"Altimmune, Inc.股价重挫14.34% 市值跌6472.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592145299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592145299?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:31","pubTimestamp":1766154672,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日22时31分,Altimmune, Inc.股票出现波动,股价大幅下挫14.34%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,爱美医疗、Neuraxis, Inc.、Gain Therapeutics, Inc.涨幅较大,Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃,换手率分别为1395.50%、187.32%、41.77%,振幅较大的相关个股有Design Therapeutics, Inc.、健永生技、Neuraxis, Inc.,振幅分别为9.41%、8.41%、7.64%。Altimmune, Inc.公司简介:Altimmune Inc 是一家处于临床阶段的生物制药公司,专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219223112a6b78e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219223112a6b78e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"1122403977","title":"Altimmune宣布Pemvidutide在Impact 2B Mash试验中48周内实现主要成功指标","url":"https://stock-news.laohu8.com/highlight/detail?id=1122403977","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122403977?lang=zh_cn&edition=full","pubTime":"2025-12-19 19:31","pubTimestamp":1766143871,"startTime":"0","endTime":"0","summary":"Altimmune宣布Pemvidutide在Impact 2B Mash试验中48周内实现主要成功指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2592344141","title":"RootData:ALT 将于一周后解锁价值约 269 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2592344141","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592344141?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:00","pubTimestamp":1766113209,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据Web3资产数据平台 RootData 代币解锁数据,AltLayer(ALT)将于北京时间 12 月 26 日 8 时解锁约 24659 万枚代币,价值约 269 万美元。 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2230980","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0},{"id":"1120348252","title":"Altimmune, Inc.申请最高达4亿美元的混合货架证券 - SEC申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1120348252","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120348252?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:05","pubTimestamp":1763571922,"startTime":"0","endTime":"0","summary":"11月7日(路透社)- Altimmune, Inc. ::*ALTIMMUNE INC申请最高达4亿美元的混合货架证券 - SEC申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"1125100430","title":"Altimmune修订与海格投资的贷款及担保协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1125100430","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125100430?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:56","pubTimestamp":1763571397,"startTime":"0","endTime":"0","summary":"11月6日 - Altimmune Inc : *ALTIMMUNE INC - 修订与海格投资的贷款及担保协议 - SEC备案*ALTIMMUNE INC - 定期贷款额度从1亿美元增至1.25亿美元 - SEC备案*ALTIMMUNE INC - 第二次定期贷款分期已提取2000万美元 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HTGC","BK4139","LU1878469433.USD","BK4599","BK4135","ALT"],"gpt_icon":0},{"id":"2584699136","title":"RootData:ALT 将于一周后解锁价值约 358 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2584699136","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584699136?lang=zh_cn&edition=full","pubTime":"2025-11-19 11:00","pubTimestamp":1763521202,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据Web3资产数据平台 RootData 代币解锁数据,AltLayer(ALT)将于北京时间 11 月 26 日 8 时解锁约 24659 万枚代币,价值约 358 万美元。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2221605","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4599","BK4139","ALT"],"gpt_icon":0},{"id":"1141343527","title":"Altimmune公布IMPACT 2B期临床试验数据在《柳叶刀》上发表,并且于2025年AASLD肝脏会议上进行最新口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1141343527","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141343527?lang=zh_cn&edition=full","pubTime":"2025-11-11 21:52","pubTimestamp":1762869133,"startTime":"0","endTime":"0","summary":"Altimmune公布IMPACT 2B期临床试验数据在《柳叶刀》上发表,并且于2025年AASLD肝脏会议上进行最新口头报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"1152579858","title":"Altimmune宣布完成Reclaim II期试验的早期招募,评估Pemvidutide在酒精使用障碍中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1152579858","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152579858?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:30","pubTimestamp":1762173015,"startTime":"0","endTime":"0","summary":"Altimmune宣布完成Reclaim II期试验的早期招募,评估Pemvidutide在酒精使用障碍中的应用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"1106997194","title":"Altimmune 将于2025年11月6日公布2025年第三季度财务业绩并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1106997194","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106997194?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:31","pubTimestamp":1761823869,"startTime":"0","endTime":"0","summary":"Altimmune 将于2025年11月6日公布2025年第三季度财务业绩并提供业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2576026610","title":"RootData:ALT 将于一周后解锁价值约 473 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2576026610","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576026610?lang=zh_cn&edition=full","pubTime":"2025-10-19 11:00","pubTimestamp":1760842802,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据Web3资产数据平台 RootData 代币解锁数据,AltLayer(ALT)将于北京时间 10 月 26 日 8 时解锁约 24659 万枚代币,价值约 473 万美元。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2213599","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2570704804","title":"Altimmune, Inc.盘中异动 下午盘股价大涨5.10%报4.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570704804","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570704804?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:17","pubTimestamp":1758820633,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日01时17分,Altimmune, Inc.股票出现异动,股价急速上涨5.10%。截至发稿,该股报4.12美元/股,成交量156.876万股,换手率1.78%,振幅6.76%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为1.23%。Altimmune, Inc.公司简介:Altimmune Inc 是一家处于临床阶段的生物制药公司,专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926011713a443f3f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926011713a443f3f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","LU1878469433.USD","BK4139"],"gpt_icon":0},{"id":"2568723690","title":"RootData:ALT 将于一周后解锁价值约 880 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2568723690","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568723690?lang=zh_cn&edition=full","pubTime":"2025-09-19 11:00","pubTimestamp":1758250806,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据Web3资产数据平台 RootData 代币解锁数据,AltLayer(ALT)将于北京时间 09 月 26 日 8 时解锁约 24659 万枚代币,价值约 880 万美元。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2206839","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4139","ALT","BK4599"],"gpt_icon":0},{"id":"2518682201","title":"Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518682201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518682201?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:21","pubTimestamp":1741630882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时21分,Altimmune, Inc.股票出现波动,股价大幅跳水5.12%。截至发稿,该股报5.29美元/股,成交量148.018万股,换手率1.92%,振幅4.90%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为5934.70%、3845.43%、1003.65%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc,振幅分别为90.44%、88.14%、59.34%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LU1878469433.USD","BK4139","ALT"],"gpt_icon":0},{"id":"2517430971","title":"Altimmune, Inc.2024财年实现净利润-95.06百万美元,同比减少7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430971?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日,Altimmune, Inc.公布财报,公告显示公司2024财年净利润为-95.06百万美元,同比减少7.47%;其中营业收入为20000.00美元,同比减少95.31%,每股基本收益为-1.34美元。从资产负债表来看,Altimmune, Inc.总负债15.80百万美元,其中短期债务279000.00美元,资产负债比为0.09,流动比率为0.14。机构评级:截至2025年3月8日,当前有8家机构对Altimmune, Inc.目标价做出预测,其中目标均价为22.38美元,其中最低目标价为12.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT"],"gpt_icon":0},{"id":"2517319420","title":"Altimmune, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517319420?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:05","pubTimestamp":1741287928,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时05分,Altimmune, Inc.股票出现波动,股价大幅下挫5.07%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.84%。其相关个股中,Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为4920.76%、3757.89%、255.79%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为125.28%、122.63%、71.44%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2516651619","title":"HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516651619?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:55","pubTimestamp":1741024555,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04015548498807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.2441},{"period":"3month","weight":-0.3359},{"period":"6month","weight":-0.0385},{"period":"1year","weight":-0.3269},{"period":"ytd","weight":-0.0305}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide(原名ALT-801)是一种GLP-1/胰高血糖素双受体激动剂,正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎(“MASH”),以前称为非酒精性脂肪性肝炎(“NASH”)。","yearOnYearQuotes":[{"month":1,"riseRate":0.421053,"avgChangeRate":0.021325},{"month":2,"riseRate":0.368421,"avgChangeRate":-0.012068},{"month":3,"riseRate":0.368421,"avgChangeRate":-0.059551},{"month":4,"riseRate":0.388889,"avgChangeRate":-0.049636},{"month":5,"riseRate":0.5,"avgChangeRate":0.064208},{"month":6,"riseRate":0.388889,"avgChangeRate":-0.000157},{"month":7,"riseRate":0.388889,"avgChangeRate":0.041853},{"month":8,"riseRate":0.444444,"avgChangeRate":0.10411},{"month":9,"riseRate":0.210526,"avgChangeRate":-0.115822},{"month":10,"riseRate":0.263158,"avgChangeRate":0.032599},{"month":11,"riseRate":0.421053,"avgChangeRate":-0.007448},{"month":12,"riseRate":0.526316,"avgChangeRate":0.184275}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}